It is a pharma private limited company based in Hyderabad, Telangana, India, established in 2020.
2020 | Hyderabad, Telangana, India | ActivePremexa Lifesciences Private Limited, a active private limited company, was established on 19 February 2020 in Hyderabad, Telangana, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24304TG2020PTC139376. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
Its leadership includes Karunakar Chinta (Director), Kannegulla Sridhar (Director), Veeresham Murki (Director). Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 5-14-45/2/130, Indira Nagar Colony Kapra, Moulaali, Hyderabad, Telangana, 500040.
U24304TG2020PTC139376
139376
19 February 2020
₹0.10 M
₹0.10 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Premexa Lifesciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Karunakar Chinta | Director | 19 Feb 2020 | Current |
| Kannegulla Sridhar | Director | 19 Feb 2020 | Current |
| Veeresham Murki | Director | 19 Feb 2020 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Premexa Lifesciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 122.16% increase. The company also saw a substantial improvement in profitability, with a 444.59% increase in profit. The company's net worth Soared by an impressive increase of 151.65%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Premexa Lifesciences had a public holding of 20.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Premexa Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Premexa Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Premexa Lifesciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Premexa Lifesciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Premexa Lifesciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was recorded as a recent event.
The activity Karunakar Chinta was appointed as a Director was appointed as a Director on 19 Feb 2020 & has been associated with this company since 5 years 9 months . was completed.
The activity Kannegulla Sridhar was appointed as a Director was appointed as a Director on 19 Feb 2020 & has been associated with this company since 5 years 9 months . was completed.
Progress on Veeresham Murki was appointed as a Director was appointed as a Director on 19 Feb 2020 & has been associated with this company since 5 years 9 months . was documented.
The activity Premexa Lifesciences Private Limited was registered on 19 Feb 2020 with Roc Hyderabad & aged 5 years 9 months as per MCA records. was completed.
The CIN of Premexa Lifesciences Private Limited is U24304TG2020PTC139376.
Premexa Lifesciences Private Limited is headquartered at 5-14-45/2/130, Indira Nagar Colony Kapra, Moulaali, Hyderabad, Telangana, 500040.
Premexa Lifesciences Private Limited was incorporated on 19 February 2020.
The current directors of Premexa Lifesciences Private Limited are
The primary industry of Premexa Lifesciences Private Limited is Trade.
Premexa Lifesciences Private Limited is unlisted.
The authorized capital of Premexa Lifesciences Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX